Nascent RNA sequencing reveals a dynamic global transcriptional response at genes and enhancers to the natural medicinal compound celastrol

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 1.
Figure 1.

Characterizing the dynamic transcriptional response to celastrol using PRO-seq. (A) PRO-seq was applied to K562 cells collected before celastrol treatment (untreated/0 min) and at 10, 20, 40, 60, and 160 min after celastrol treatment. Two biological replicates were performed for each time point. (B) Distribution of log expression ratios (treated vs. untreated) for each time point (rlog is a regularized log2 estimate obtained from DESeq2). Only genes classified as differentially expressed (DE) throughout the time course are represented. Notice that most DE genes (FDR ≤ 0.01) are down-regulated upon celastrol treatment. (C) A UCSC Genome Browser display showing raw PRO-seq data for two differentially expressed genes, EGR1 and KDM3B. EGR1 is rapidly and strongly repressed (immediate decrease of ∼80%), whereas KDM3B is more gradually repressed, losing ∼50% of its expression by 160 min.

This Article

  1. Genome Res. 27: 1816-1829

Preprint Server